Search
Search through the thousands of lawsuits, complaints and recalls on our site.

Drugs / Medicines Recalls and Alerts

Report Fraud

Pascal Company, Inc. recalls all lots and all flavors of NeutraGard 0.05% Neutral Sodium Fluoride Anticavity Treatment Rinse and NeutraGard Plus 0.2% Neutral Sodium Fluoride Anticavity Treatment Rinse

Date: 5/1/2006
Reason: Products may be contaminated with Burkholderia cepacia and Pseudomonas aeruginosa bacteria
Distribution: Nationwide.

Need Legal Help?

Does this recall or safety alert affect you or your family?

Pascal Company, Inc., located in Bellevue, Washington, is recalling all lots and all flavors of their products, NeutraGard 0.05% Neutral Sodium Fluoride Anticavity Treatment Rinse and NeutraGard Plus 0.2% Neutral Sodium Fluoride Anticavity Treatment Rinse, all flavors (Mint and Tropical Blast) packaged in clear 16 oz plastic bottles because they may be contaminated with bacteria called Burkholderia cepacia and Pseudomonas aeruginosa.

The organism, Burkholderia cepacia poses little medical risk to healthy people. However, people who have certain health problems like weakened immune systems or chronic lung diseases, particularly cystic fibrosis (CF), may be more susceptible to infections with B. cepacia. B cepacia is a known cause of infections in hospitalized patients. The effects of B. cepacia on people vary widely, ranging from no symptoms at all, to serious respiratory infections, especially in patients with CF.

The organism, Pseudomonas aeruginosa may cause urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, gastrointestinal infections and a variety of systemic infections, particularly in patients with severe burns and in cancer and AIDS patients who are immunosuppressed. Pseudomonas aeruginosa infection is a serious problem in patients hospitalized with cancer, cystic fibrosis, and burns.

Pascal Company, Inc. has initiated a recall to the consumer level. Approximately 55,000 bottles were distributed worldwide since 2001 to dental wholesalers, who in turn distributed the products to dental offices. These products were not available at any retail outlets or pharmacies.

The problem was discovered during recent testing of samples stored for long-term studies conducted after the products were distributed. Only a small number of batches produced since 2001 showed the presence of these organisms, primarily in batches distributed prior to 2005. A majority of batches tested negative for the presence of these organisms. However, because Pascal Co., Inc. did not test all batches, the company has decided to issue a recall for all batches distributed since 2001.

Consumers and dental offices that have the product should discontinue use of the product and destroy it immediately, or return it to their place of purchase for further processing. Consumers with questions regarding the recall may contact Pascal Company, Inc. at 800-426-8051, or go to http://www.pascaldental.com, and click on the NeutraGard Rinse recall link. This recall is being made in cooperation with the U.S. Food and Drug Administration.

Any adverse reactions experienced with the use of this product should also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, HF-410, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at http://www.fda.gov/medwatch.


Other Drugs / Medicines Recalls and Alerts of Interest

Date: 6/12/2008
Reason: Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS)

Distribution: Nationwide
 
Date: 6/12/2008

Reason: Taking AZASAN® instead of SOLODYN® presents a health hazard and safety risk to patients

Distribution: Nationwide

 
Date: 6/12/2008

Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate

Distribution: Nationwide

 
Date: 6/12/2008
Reason: Limited lots of Carmeda-coated products were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS).

Distribution: Nationwide
 
Date: 6/16/2008
Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate

Distribution: Nationwide
 
Date: 6/12/2008
Reason: it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil

Distribution: Nationwide
 

Become a LawCash Member - FREE!
'Find Money' E-Book
Weekly Email Alerts




privacy policy
YouNewz Beta
IT'S FREE

Report

Report Newz and easily upload your own newzworthy photos from your cell phone or computer to the web.

Share

Quickly share your photos with family, friends, co-workers, or the world with your own Newzpaper.

Read

Instantly find Newz and photos from other YouNewzers and read other YouNewzers Newzpapers.
 
Class Action Lawsuit Center || Product Recall Center || Consumer Complaint Center || About LawCash Link Exchange
Privacy Policy || Legal Policies || Terms & Conditions || Website Advertising Policy || Site Map || Top Lawsuits
LawCash® is a service of nola3, llc
© 2000 - 2008 Copyright. All rights reserved nola3, llc.

[ Home ]
LawCash
login
Justice is a click away.